2021
DOI: 10.1080/07391102.2021.1966508
|View full text |Cite
|
Sign up to set email alerts
|

Phytochemical constituents ofInula britannicaas potential inhibitors of dihydrofolate reductase: A strategic approach against shigellosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 73 publications
0
3
0
Order By: Relevance
“…Diverse natural metabolites of various structural classes, including terpenoids, have been assessed for their DHFR inhibition (DHFRI) capacity using in silico or in vitro approaches [ 21 , 22 , 23 , 24 ]. For example, cynaropicrin is a sesquiterpene lactone reported from artichoke that has notable DHFRI potential (IC 50 7.1 µM) [ 24 ].…”
Section: Resultsmentioning
confidence: 99%
“…Diverse natural metabolites of various structural classes, including terpenoids, have been assessed for their DHFR inhibition (DHFRI) capacity using in silico or in vitro approaches [ 21 , 22 , 23 , 24 ]. For example, cynaropicrin is a sesquiterpene lactone reported from artichoke that has notable DHFRI potential (IC 50 7.1 µM) [ 24 ].…”
Section: Resultsmentioning
confidence: 99%
“…Luteolin 3'-methyl ether (chrysoeriol) from P. britannicum, based on in silico studies was selected as a potential inhibitor of dihydrofolate reductase (DHFR-1) and may be considered as a potential therapeutic agent in Shigella dysenteriae type 1 infections [301].…”
Section: Biological Activity Of Flavonesmentioning
confidence: 99%
“…Other flavonols from C. iphionoides, kaempferol 3,7-dimethyl ether (kumatakenin) and quercetin 3,3'-dimethyl ether demonstrated antifungal activity and inhibited aggregation of human blood platelets induced by both ADP and collagen [146,147]. Quercetagetin 6,7,4'-trimethyl ether, based on in silico studies on P. britannicum metabolites, was selected for the further investigation as a potential inhibitor of dihydrofolate reductase that may find use in the therapy of shigellosis [301].…”
Section: Biological Activity Of Flavonolsmentioning
confidence: 99%